Results 1 to 10 of about 778,689 (289)

Investigation of multi-infections and breast disease comorbidities in granulomatous mastitis. [PDF]

Ann Med Surg (Lond)
Esmaeil NK, Salih AM.
europepmc   +2 more sources

A systematic review of determinants of breast cancer risk among women with benign breast disease. [PDF]

NPJ Breast Cancer
Burke A, O'Driscoll J, Abubakar M, Bennett KE, Carmody E, Flanagan F, Gierach GL, Mullooly M.   +7 more
europepmc   +3 more sources

Breast disease [PDF]

Medical Clinics of North America, 1995
Breast diseases are a common aspect of primary care practice. Common benign and malignant breast diseases are reviewed. The evaluation of common breast problems is presented and current recommendations for diagnostic and screening mammography are discussed.
A L, Bradley, K W, Sharp
openaire   +4 more sources

Successful treatment of pyoderma gangrenosum after reducing mammoplasty: a case report [PDF]

Revista Brasileira de Cirurgia Plástica, 2021
Introduction: Pyoderma gangrenosum is a rare inflammatory disease characterized by the presence of ulcerated lesions. The etiology is unknown but apparently relates to immunological factors.
Gisela Hobson Pontes, Fernando Sergio Mendes-Carneiro-Filho, Luis Alejandro Vargas Guerrero   +2 more
doaj   +1 more source

Huaier polysaccharides suppress triple-negative breast cancer metastasis and epithelial-mesenchymal transition by inducing autophagic degradation of Snail

Cell & Bioscience, 2021
Background Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, and the targeted therapies are lacking for this type of cancer.
Yuan Tian, Jin Wu, Lingjuan Zeng, Linxi Zhou, Ying Hu, Qinwen Pan, Wei Liu, Yuzhao Yan, Ziwei Wu, Zhaoyu Wang, Zhen Zeng, Peng Tang, Jun Jiang, Minghao Wang   +13 more
doaj   +1 more source

Brain metastasis in de novo breast cancer: An updated population-level study from SEER database

Asian Journal of Surgery, 2022
Purpose: Although there are current studies on breast cancer brain metastasis, population-level analysis is still lacking. As treatment for metastatic breast cancer has improved, an updated population-level analysis is necessary.
Ming-Shuai Sun, Yong-Yang Yun, Hong-Jin Liu, Zheng-Heng Yu, Fan Yang, Ling Xu   +5 more
doaj   +1 more source

Neoadjuvant therapy for early human epidermal growth factor receptor 2 positive breast cancer in China: A multicenter real-world study (CSBrS-015)

Chinese Medical Journal, 2022
. Background:. Pertuzumab has been approved for application in China by the National Medical Products Administration, and both national and international guidelines make recommendations for the use of neoadjuvant treatment with trastuzumab or trastuzumab
Yuanjia Cheng, Hongyu Xiang, Ling Xin, Xuening Duan, Yinhua Liu, Yuanyuan Ji, Chinese Society of Breast Surgery (CSBrS), Chinese Society of Surgery of Chinese Medical Association   +6 more
doaj   +1 more source

IR792-MCN@ZIF-8-PD-L1 siRNA drug delivery system enhances photothermal immunotherapy for triple-negative breast cancer under near-infrared laser irradiation

Journal of Nanobiotechnology, 2022
Background Despite extensive investigations on photothermal therapy, the clinical application is restricted due to poor stability, low therapeutic efficacy of photothermal therapy agents and its affinity loss in the multistep synthesis of delivery ...
Yongmei Wang, Haibo Wang, Yuhua Song, Meng Lv, Yan Mao, Hongming Song, Yuanyuan Wang, Gang Nie, Xiaoyi Liu, Jian Cui, Xueqing Zou   +10 more
doaj   +1 more source

LncRNA SRA gene polymorphisms and risk of gynecological pathology development among Ukrainian women with proliferative type of benign breast disease without atypia

Zaporožskij Medicinskij Žurnal, 2021
Benign breast disease is a group of all noncancerous mammary lesions with a risk of breast cancer (BC) development. BC is the most common cancer in the world; therefore, it is necessary to find new biomarkers and targets for early diagnosis, treatment ...
I. M. Lukavenko, A. V. Kolnoguz, V. Yu. Harbuzova, O. V. Ataman   +3 more
doaj   +1 more source

Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SEER population-based analysis

BMC Cancer, 2021
Background Previous studies have reported poor survival rates in inflammatory breast cancer (IBC) patients than non-inflammatory local advanced breast cancer (non-IBC) patients.
Dechuang Jiao, Jingyang Zhang, Jiujun Zhu, Xuhui Guo, Yue Yang, Hui Xiao, Zhenzhen Liu   +6 more
doaj   +1 more source